Concepedia

Daniel Burge

DB

Statistics

Publications

16

Citations

5.1K

H-Index

14

Active since

1999

Affiliations

Resolve Therapeutics (United States)(Current)

Altoona Center for Clinical Research

Metroplex Clinical Research Center

Center for Rheumatology

Dermira (United States)

Daniel Burge is an author at Resolve Therapeutics (United States) specializing in medicine, rheumatology, and pharmacotherapy.

Publications per year

1999–2024

16

Publications

16

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Michael E. Weinblatt, Joel M. Kremer, Arthur D. Bankhurst et al. · New England Journal of Medicine · 1999 · 2.1K citations · Full text

, , +17

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Philip J. Mease, Bernard S. Goffe, James M. Metz et al. · The Lancet · 2000 · 1.5K citations

, , +6

Once‐weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Edward Keystone, Michael Schiff, Joel M. Kremer et al. · Arthritis & Rheumatism · 2004 · 286 citations

, , +8

Long‐term efficacy and safety of etanercept in children with polyarticular‐course juvenile rheumatoid arthritis: Interim results from an ongoing multicenter, open‐label, extended‐treatment trial

Daniel J. Lovell, Edward H. Giannini, Andreas Reiff et al. · Arthritis & Rheumatism · 2003 · 256 citations

, , +14

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.

Larry W. Moreland, S. Cohen, Scott W. Baumgartner et al. · PubMed · 2001 · 201 citations

, , +15

1–5 of 16